Banque Pictet & Cie Sa Guardant Health, Inc. Transaction History

Banque Pictet & Cie Sa

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$43.66 - $61.0 $400,886 - $560,102	-9,182 Reduced 8.04%	104,962 $5.65 Billion
Q2 2022 Aug 08, 2022	SELL	$28.82 - $77.35 $120,179 - $322,549	-4,170 Reduced 3.52%	114,144 $4.61 Million
Q1 2022 May 04, 2022	BUY	$48.25 - $100.49 $681,483 - $1.42 Million	14,124 Added 13.56%	118,314 $7.84 Million
Q4 2021 Feb 02, 2022	BUY	$88.71 - $120.43 $7.64 Million - $10.4 Million	86,082 Added 475.38%	104,190 $10.4 Million
Q3 2021 Nov 10, 2021	BUY	$98.77 - $132.17 $443,674 - $593,707	4,492 Added 32.99%	18,108 $2.26 Million
Q2 2021 Aug 12, 2021	BUY	$109.77 - $165.68 $395,062 - $596,282	3,599 Added 35.93%	13,616 $1.69 Million
Q1 2021 May 11, 2021	BUY	$127.04 - $179.1 $1.27 Million - $1.79 Million	10,017 New	10,017 $1.53 Million

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

Stay updated on Banque Pictet & Cie Sa with notifications on news.